Open Access

Associations of FoxP3 gene polymorphisms with severe recurrent respiratory papillomatosis in Korean patients

  • Tack-Kyun Kwon1,
  • Eun Jae Chung1,
  • Nuri Lee2,
  • Eun Youn Roh2 and
  • Eun Young Song2Email author
Journal of Otolaryngology - Head & Neck Surgery201746:21

https://doi.org/10.1186/s40463-017-0197-z

Received: 19 December 2016

Accepted: 13 March 2017

Published: 15 March 2017

Abstract

Background

FoxP3 is the most dependable marker for regulatory T cells which play a major role in immune tolerance. Foxp3 gene polymorphisms were associated with various autoimmune diseases and clearance of viral infections. We studied the association of Foxp3 polymorphisms in severe RRP patients.

Methods

A total of 30 Korean severe RRP patients and 195 healthy controls were enrolled. Foxp3 polymorphisms (rs5902434 del/ATT, rs3761548 C/A, rs3761549 C/T, and rs2232365 G/A) were determined by PCR and sequencing.

Results

Genotype frequencies (GF) of rs5902434 ATT/ATT and rs2232365 GG were significantly decreased in female RRP patients than controls (0.0% vs 23.0%, p = 0.039, OR = 9.4 for both).

Conclusions

We showed that Foxp3 polymorphism of rs5902434 and rs2232365 could be an important protective factor in the susceptibility of severe RRP in female Koreans. Further studies on larger number of patients and other ethnic groups are needed to clarify the association.

Keywords

Disease susceptibility Foxp3 Human papilloma virus Recurrent respiratory papillomatosis Single nucleotide polymorphism

Background

Regulatory T (Treg) cells are involved in diseases characterized by dysregulated peripheral tolerance, such as autoimmune diseases and viral reactivation. Forkhead box P3 (FoxP3) is a transcription factor that regulates Treg development and function, and is still the most reliable marker for Treg [1].

Recurrent respiratory papillomatosis (RRP) is a rare benign neoplasm of the larynx and trachea characterized by frequent recurrences of papilloma of the airway with significant morbidity. Although it is caused by human papillomavirus (HPV) types 6 and 11, it is unclear why only a very small fraction of HPV-exposed subjects develop RRP [2]. In RRP patients, complete eradication of HPV is rare, which implicates defects in the host cell-mediated immune response [3]. Recently, the increase of Treg in papilloma tissue but exhaustion and chronic activation of Treg have been reported [4]. Foxp3 gene polymorphisms in promoter region could affect the function and quantity of Foxp3 molecule, which results in defects in Treg function, have been associated with various autoimmune disease and clearance of viral infections [5, 6]. In this study, we analyzed the association of four Foxp3 polymorphisms (rs5902434 del/ATT, rs3761548 C/A, rs3761549 C/T, and rs2232365 G/A) in promoter region in Korean severe RRP patients.

Methods

RRP patients and control subjects

A total of 30 patients (26 adults and 4 children) who underwent surgery for severe RRP in the period from Feb 2010 to Dec 2010 at Seoul National University Hospital were included in this study. The mean age of patients was 41.2 years (4–80 years). Clinical severity was determined by the extent of disease at the time of surgery and the frequency of recurrence as previously described [7]. At each surgery, the clinical and anatomical scores were documented to yield a total score according to previously suggested staging system [8]. The mean growth rate of multiple surgeries was used to define the overall severity score for an individual patient. An overall disease severity score of ≥ 0.06, or more than three surgeries in the previous 12 months, or tracheal extension, was defined as severe RRP [7]. Out of 15 female RRP patients, four patients had medical history of immune-related disorder; Pityriasis lichenoides chronica, Immune chronic urticaria, Erysipelas, and allergic reaction to various drugs such as NSAIDs, cefazolin, and radiocontrast agent, respectively. Out of 15 male RRP patients, one patient had allergic history to radiocontrast agent. Ethylenediamine tetraacetic acid (EDTA) blood samples were collected at the time of operation. Informed consents were obtained from all patients. This study was approved by the institutional review board at our institution (IRB No. 1403-018-562). For normal controls, 195 healthy Koreans were used.

Genotyping of FoxP3 gene polymorphisms

In 30 patients, genomic DNA was prepared from peripheral blood using a QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA). Four FoxP3 polymorphisms (rs5902434 del/ATT, rs3761548 C/A, rs3761549 C/T and rs2232365 G/A) were analyzed by PCR-sequencing (Table 1). PCR was performed with a total of 40 uL reaction mixture containing 40 ng DNA, 2 uL of 10 pmole/uL concentration of each primer, 0.8 uL of each 10 mM dNTP mix, 2.0 mM MgCl2 and 1.0 U Taq DNA polymerase (Roche applied science, Basel, Switzerland) with 4uL of 10X reaction buffer. Protocol consisted of an initial denaturation step at 95 °C for 5 min; 30 cycles of 30 s denaturation step at 95 °C, 30 s annealing step at each annealing temperature (Table 1) and 30 s extension step at 72 °C, and with a 5 min final extension step at 72 °C.
Table 1

Sequencing primers

Polymorphism

Primer

5′-3′

Length (bps)

AT

rs5902434

FP3-1 F

CTGCTCTCCCCTACCAGATG

196 bp

56 °C

del/ATT

FP3-1R

CCCTGCCCATGCATTAAGTA

  

rs3761548

FP3-2 F

TTGTCTACTCCACGCCTCTCC

373 bp

60 °C

C/A

FP3-2R

TGCCTCCATCATCACCACG

  

rs3761549

FP3-4 F

GTCCTCTCCACAACCCAAGA

250 bp

60 °C

C/T

FP3-4R

CAGATTTTTCCGCCATTGAC

  

rs2232365

FP3-3 F

GAGGGCTTTCAAGGTGAGGA

371 bp

60 °C

G/A

FP3-3R

GGGAGTTGGATTGGGTGCA

  

bps base pairs, AT annealing temperature

Five μL of the PCR products were mixed with 2 μL of ExoSAP-IT PCR Clean Up (Affymetrix, Inc., Santa Clara, CA, USA) and were incubated at 37 °C for 15 min and 80 °C for 15 min. Four uL of BigDye Terminator Ready Reaction Mix (Life technologies, Grand Island, NY, USA), 1 uL of 5 pmole/uL sequencing primer, and 4 uL of deionized water were added to 1 uL of purified PCR product with 30 thermal cycles (96 °C for 10 s, 50 °C for 5 s, and 60 °C for 4 min). Two uL of 3 M sodium acetate/EDTA buffer (pH 4.6) and 25 uL of absolute EtOH were added. After vigorous vortexing and centrifugation at 2000 g for 30 min, supernatant was removed. Addition of 50 uL of 80% EtOH and centrifugation at 2000 g for 5 min were repeated twice. Fifteen uL of Hi-Di Formamide (Life technologies, Grand Island, NY, USA) was added and heated for 4 min at 95 °C. Samples were loaded on ABI 3730XL DNA analyzer (Applied Biosystems, Foster City, CA, USA). The electropherograms were processed using Chromas Lite 2.1.1 (Technelysium Pty Ltd., Brisbane, Australia).

Statistical analysis

The SNPs were selected based on CHB haplotype data using the HAPMAP database (http://www.hapmap.org). Observed genotype frequency was tested by Hardy–Weinberg equilibrium (HWE) on males and females separately because FoxP3 gene is located on Xp11.23. Odds ratio (OR) and confidence interval (CI) were calculated. Frequencies of the genotypes of four FoxP3 polymorphisms in RRP patient and controls were compared by Fisher’s exact test or Chi-square test as appropriate, and also on males and females separately, because FoxP3 gene maps to Xp11.23. The level of significance was set at p < 0.05, and odds ratios (ORs) with 95% confidence intervals (CI) were calculated for those comparisons showing significant p values.

Results

Genotype frequencies (GF) of FoxP3 polymorphisms in RRP patients and controls are presented in Table 2. GF of FoxP3 polymorphisms in male RRP patients are not different from those in controls. GF of rs5902434 del/ATT were significantly increased in female RRP patients than controls (66.7% vs 43.0%, p = 0.043, OR = 3.1 [95% CI, 1.0-9.7]). GF of rs5902434 ATT/ATT were significantly decreased in female RRP patients than controls (0.0% vs 23.0%, p = 0.039, OR = 9.4 [95% CI, 1.1-163.1]). GF of rs2232365 AG were significantly increased in female RRP patients than controls (73.3% vs 43.0%, p = 0.028, OR = 3.6 [95% CI, 1.1-12.2]). GF of rs2232365 GG was significantly decreased in female RRP patients than controls (0.0% vs 23.0%, 761548, p = 0.039, OR = 9.4 [95% CI, 1.1-163.1]). GF of rs3761548 A/C and rs3761549 showed no statistically significant difference between RRP patients and controls.
Table 2

Associations of FOXp3 polymorphisms with RRP

 

Total (n = 225)

Male (n = 110)

Female (n = 115)

Case  (n = 30)

Control (n = 195)

 

Case (n = 15)

Control

(n = 95)

 

Case (n = 15)

Control (n = 100)

  

n (%)

n (%)

p

n (%)

n (%)

p

n (%)

n (%)

p

OR (95% CI)

Age, mean

(range)

41.2

(4–80)

53.0

(41–71)

ns

42.5

(4–80)

55.1

(41–70)

ns

40.3

(7–69)

51.0

(41–71)

ns

 

rs5902434

 del/del

15(50.0)

99(50.8)

ns

10(66.7)

65(68.4)

ns

5(33.3)

34(34.0)

ns

 

 del/ATT

10(33.3)

43(22.1)

ns

   

10(66.7)

43(43.0)

0.043

3.1 (1.0–9.7)

 ATT/ATT

5(16.7)

53(27.2)

ns

5(33.3)

30(31.6)

ns

0(0.0)

23(23.0)

0.039

9.4 (1.1–163.1)

 del allele

30(66.7)

176(59.7)

ns

10(66.7)

65(68.4)

ns

20(66.7)

111(55.5)

ns

 

rs3761548

 CC

24(80.0)

141(72.3)

ns

12(80.0)

81(85.3)

ns

12(80.0)

60(60.0)

ns

 

 AC

3(10.0)

34(17.4)

ns

   

3(20.0)

34(34.0)

ns

 

 AA

3(10.0)

20(10.3)

ns

3(20.0)

14(14.7)

ns

0(0.0)

6(6.0)

ns

 

 C allele

39(86.7)

235(79.7)

ns

12(80.0)

81(85.3)

ns

27(90.0)

154(77.0)

ns

 

rs3761549

 CC

20(66.7)

141(72.3)

ns

13(86.7)

79(83.2)

ns

7(46.7)

62(62.0)

ns

 

 CT

8(26.7)

33(16.9)

ns

   

8(53.3)

33(33.0)

ns

 

 TT

2(6.7)

21(10.8)

ns

2(13.3)

16(16.8)

ns

0(0.0)

5(5.0)

ns

 

 T allele

35(77.8)

236(80.0)

ns

13(86.7)

79(83.2)

ns

22(73.3)

157(78.5)

ns

 

rs2232365

 AA

14(46.7)

100(51.3)

ns

10(66.7)

66(69.5)

ns

4(26.7)

34(34.0)

ns

 

 AG

11(36.7)

43(22.1)

ns

   

11(73.3)

43(43.0)

0.028

3.6 (1.1–12.2)

 GG

5(16.7)

52(26.7)

ns

5(33.3)

29(30.5)

ns

0(0.0)

23(23.0)

0.039

9.4 (1.1–163.1)

 A allele

29(64.4)

177(60.0)

ns

10(66.7)

66(69.5)

ns

19(63.3)

111(55.5)

ns

 

RRP recurrent respiratory papillomatosis,OR odds ratio, CI confidence interval

Discussion

It is still not known why only a very small proportion of HPV-exposed subjects have recurrent respiratory papillomatosis (RRP). The local HPV-specific immune responses that allow chronic HPV-6 and -11 infections in RRP patients was suggested. As a possible mechanism, the dominance of Th2-like cytokine (IL-4 and IL-10) responses and decreased secretion of IFN-γ were reported by peripheral blood mononuclear cells (PBMC) exposed to autologous papilloma tissues in patients with RRP [9]. Recently, impaired function of Tregs was also suggested as a possible mechanism for developing RRP [4].

FoxP3 is crucial regulatory factor for the development and function of Tregs. Polymorphisms have been reported in various regions of the FOXP3 gene, including the promoter, intron and exon regions. Promoters are relevant to initiating transcription and are therefore might harbor functionally involved polymorphisms [10]. Polymorphisms of FOXP3 gene promoter may affect the function or quantity of Treg, resulting in various autoimmune diseases. Therefore, Foxp3 gene promoter polymorphisms were associated with various autoimmune diseases [5] and CMV infection in pediatric allogeneic hematopoietic stem cell transplantation [11].

In our study, rs3761548, which was frequently reported to be associated with various diseases [5] showed no association with RRP patients. However, rs5902434 ATT/ATT genotype and rs2232365 GG genotype were significantly decreased in female RRP patients than controls. The rs5902434 del/del genotype was significantly associated with lupus nephritis in Taiwanese [12], and preeclampsia in Chinese [6], but, was not associated with allergic rhinitis [13] and unexplained recurrent spontaneous abortion [14]. The rs2232365 GG genotype was associated with unexplained recurrent spontaneous abortion [14] in Chinese, but showed no association with psoriasis [15] and Crohn’s disease [16]. Polymorphisms of FOXP3 gene promoter may change the binding specificity of transcription factors and are related to initiating transcription, therefore, may affect the function or quantity of Treg [17], resulting in various autoimmune diseases. The reason why the impacts are various in different disease and ethnic groups should be further elucidated. In our study, the associations of FoxP3 polymorphisms were observed only in female RRP patients. FoxP3 gene is located on Xp11.23. Lyonization of X-chromosome results in only two phenotypes for each polymorphism, which might affect the pathogenesis of RRP in females, should be also clarified in further studies.

Interestingly, for both rs5902434 and rs2232365, the frequencies of heterozygote were significantly higher in female RRP patients than controls. The unusual associations of heterozygote of FoxP3 rs3761548 (AC genotype) have been reported in allergic rhinitis [13] and Graves’ disease [18]. The mechanism is not clear yet, but the heterozygosity of Foxp3 polymorphism itself may have unknown but considerable effects on the pathogenesis of various autoimmune disease and also on RRP.

Conclusions

In conclusion, polymorphisms of FoxP3 rs5902434 and rs2232365 were associated with female RRP in Koreans. These results suggest the possible role of Foxp3 polymorphisms in immune tolerance of HPV infection in RRP pathogenesis. Further studies in larger number of patients including other ethnic groups are needed.

Abbreviations

EDTA: 

Ethylenediamine tetraacetic acid

FoxP3: 

Forkhead box P3

GF: 

Genotype frequencies

HPV: 

Human papillomavirus

PBMC: 

Peripheral blood mononuclear cells

RRP: 

Recurrent respiratory papillomatosis

Treg: 

Regulatory T

Declarations

Acknowledgements

Not applicable.

Funding

This study was supported by a grant number 0320150180 from the SNUH research fund.

Availability of data and materials

Data can be requested by contacting the corresponding author.

Authors’ contributions

TK, EJ, NL, EY, and EY have participated in the concept and design, analysis and interpretation of data, drafting and/or revising the manuscript, and have approved the manuscript as submitted.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

We got informed consents for our study from all participating patients.

Ethics approval and consent to participate

This study was approved by the institutional review board at Seoul National University Hospital (IRB No. 1403-018-562).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Otolaryngology-Head and Neck Surgery, Seoul National University College of Medicine
(2)
Department of Laboratory Medicine, Seoul National University College of Medicine

References

  1. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.View ArticlePubMedGoogle Scholar
  2. Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: clinical histopathologic and molecular studies. Laryngoscope. 1987;97:678–85.View ArticlePubMedGoogle Scholar
  3. Bonagura VR, Hatam LJ, Rosenthal DW, de Voti JA, Lam F, Steinberg BM, et al. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS. 2010;118:455–70.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Hatam LJ, Devoti JA, Rosenthal DW, Lam F, Abramson AL, Steinberg BM, et al. Immune suppression in premalignant respiratory papillomas: enriched functional CD4 + Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression. Clin Cancer Res. 2012;18:1925–35.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Oda JM, Hirata BK, Guembarovski RL, Watanabe MA. Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases. J Genet. 2013;92:163–71.View ArticlePubMedGoogle Scholar
  6. Chen X, Gan T, Liao Z, Chen S, Xiao J. Foxp3 (-/ATT) polymorphism contributes to the susceptibility of preeclampsia. PLoS One. 2013;8, e59696.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, et al. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol. 2004;65:773–82.View ArticlePubMedGoogle Scholar
  8. Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope. 1998;108:935–7.View ArticlePubMedGoogle Scholar
  9. DeVoti JA, Steinberg BM, Rosenthal DW, Hatam L, Vambutas A, Abramson AL, et al. Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis. Clin Diag Lab Immunol. 2004;11:538–47.Google Scholar
  10. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR, et al. Functional analysis of human promoter polymorphisms. Hum Mol Genet. 2003;12:2249–54.View ArticlePubMedGoogle Scholar
  11. Piao Z, Kim HJ, Choi JY, Hong CR, Lee JW, Kang HJ, et al. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients. Int Immunopharmacol. 2016;31:132–9.View ArticlePubMedGoogle Scholar
  12. Lin YC, Lee JH, Wu AS, Tsai CY, Yu HH, Wang LC, et al. Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case–control study. Lupus. 2011;20:137–43.View ArticlePubMedGoogle Scholar
  13. Zhang L, Zhang Y, Desrosiers M, Wang C, Zhao Y, Han D. Genetic association study of FOXP3 polymorphisms in allergic rhinitis in a Chinese population. Hum Immunol. 2009;70:930–4.View ArticlePubMedGoogle Scholar
  14. Wu Z, You Z, Zhang C, Li Z, Su X, Zhang X, et al. Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population. Clin Dev Immunol. 2012;2012:896458.PubMedGoogle Scholar
  15. Gao L, Li K, Li F, Li H, Liu L, Wang L, et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci. 2010;57:51–6.View ArticlePubMedGoogle Scholar
  16. Park O, Grishina I, Leung PS, Gershwin ME, Prindiville T. Analysis of the Foxp3/scurfin gene in Crohn’s disease. Ann N Y Acad Sci. 2005;1051:218–28.View ArticlePubMedGoogle Scholar
  17. Hanel SA, Velavan TP, Kremsner PG, Kun JF. Novel and functional regulatory SNPs in the promoter region of FOXP3 gene in a Gabonese population. Immunogenetics. 2011;63:409–15.View ArticlePubMedGoogle Scholar
  18. Inoue N, Watanabe N, Morita M, Tomizawa R, Akamizu T, Tatsumi K, et al. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Experimental Immunol. 2010;162:402–6.View ArticleGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement